Healthcare stakeholders’ consensus response to the proposed European Health Data Space

ESHRE joined a group of 35 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space and shares stakeholders’ recommendations on how to make the digital transformation a success across Europe.


Help us update our Istanbul consensus recommendations by completing a 20-minutes online survey

The Istanbul consensus recommendations on the oocyte and embryo morphology assessment are currently applied worldwide. However, there is need to update these recommendations following the technologic and scientific advances in the field.
As a first step in this project, ESHRE and Alpha Scientists have set out to map the current practice regarding the oocyte and embryo morphology assessment and document the attitudes of professionals towards the Istanbul consensus recommendations. The aim is to identify areas for which improvement of the existing recommendations or formulating of new recommendations is highly relevant.


Register now for the 2023 Best of ESHRE and ASRM

The Best of ESHRE & ASRM joint conference brings together international leaders in the field of Reproductive Medicine. Along with plenary talks from experts throughout Europe and the United States, you will also experience innovative idea sharing during our “Cutting Edge” sessions, gain an understanding of the thought differences during our “Back-to-Back” sessions, while pro and con discussions will spark conversation in the “Debate” sessions.


ESHRE wins EU4Health Grant for monitoring of Medically Assisted Reproduction

ESHRE was recently awarded an EU4HEALTH project grant of 1.2 million euro for the development of the EuMAR data registry. The EuMAR data registry will be the first ‘overarching’ European, standardised, web-based data registry, containing high-quality cycle-by-cycle data entries from medical professionals across the EU. The EuMAR registry aims to facilitate data sharing for open science across institutes and to allow the longitudinal and cross-border follow up of medically assisted reproduction (MAR) data.